JUBILANT PHARMOVA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 678.4 INR | +0.80% |
|
-0.91% | +24.32% |
| 04-25 | Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA | MT |
| 04-17 | Jubilant Pharmova Unit Gets VAI Status for Roorkee, India Facility | MT |
Chart calendar Jubilant Pharmova Limited
94ab1fa10d786d708879.U4WqdoJSkeAf6RMzeMER5QNvmO2kiO4PZT0dngwtLPA.AOP6Gu8_ybddjVZiD5l0qmA-16jDsYlrKnlb2zlPfZRn9MkiyzDYkiaESg~55c21a75499bec8b6f3861f797c1a5be
Upcoming events on Jubilant Pharmova Limited
Past events on Jubilant Pharmova Limited
| 11/03/2024 | Investor Meeting - JM Financial MF |
| 02/02/2024 08:54 | Q3 2024 Earnings Release |
| 01/02/2024 | Q3 2024 Earnings Call |
| 27/10/2023 09:58 | Q2 2024 Earnings Release |
| 31/08/2023 06:30 | Annual General Meeting |
| 09/08/2023 | Ex-dividend day for final dividend |
| 19/07/2023 09:35 | Q1 2024 Earnings Release |
| 18/07/2023 | Q1 2024 Earnings Call |
| 29/05/2023 | Q4 2023 Earnings Call |
| 29/05/2023 11:15 | Q4 2023 Earnings Release |
| 03/02/2023 10:30 | Q3 2023 Earnings Call |
| 03/02/2023 07:33 | Q3 2023 Earnings Release |
| 21/10/2022 12:30 | Interim 2023 Earnings Call |
| 21/10/2022 09:14 | Interim 2023 Earnings Release |
| 26/09/2022 06:30 | Annual General Meeting |
| 10/08/2022 | Ex-dividend day for final dividend |
| 02/08/2022 12:30 | Q1 2023 Earnings Call |
| 02/08/2022 08:28 | Q1 2023 Earnings Release |
| 27/05/2022 12:30 | FY 2022 Earnings Call |
| 27/05/2022 12:00 | FY 2022 Earnings Release |
Past dividends on Jubilant Pharmova Limited
| 09/08/2023 | Annual 5 INR |
| 10/08/2022 | Annual 5 INR |
| 04/08/2021 | Annual 5 INR |
| 08/03/2020 | Interim Payment 5 INR |
| 11/09/2019 | Annual 4.5 INR |
| 11/09/2018 | Annual 3 INR |
| 15/08/2017 | Annual 3 INR |
| 17/08/2016 | Annual 3 INR |
| 19/08/2015 | Annual 3 INR |
| 20/08/2014 | Annual 3 INR |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 91 108 90 098 1.12% | 91 544 91 402 0.16% | 89 055 76 860 15.87% | 61 302 59 772 2.56% | 62 817 64 227 -2.19% |
|
EBITDA Million INR | Released Forecast Spread | 17 390 18 582 -6.42% | 19 471 18 327 6.24% | 13 965 18 200 -23.27% | 11 563 11 244 2.84% | 7 763 9 927 -21.8% |
|
EBIT Million INR | Released Forecast Spread | 13 681 14 729 -7.11% | 14 852 14 593 1.77% | 10 475 14 389 -27.2% | 7 746 7 592 2.04% | 0,00 0,00 - |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 9 038 12 796 -29.37% | 12 105 11 622 4.16% | 12 120 12 093 0.22% | 6 404 6 377 0.43% | 278 5 325 -94.78% |
|
Net income Million INR | Released Forecast Spread | 5 745 9 210 -37.62% | 8 982 8 655 3.79% | 8 359 8 278 0.97% | 4 139 4 253 -2.68% | -610 3 016 -120.22% |
|
EPS INR | Released Forecast Spread | 36,9 58,3 -36.77% | 56,4 54,5 3.52% | 52,5 53,3 -1.49% | 26,0 27,2 -4.24% | -3,83 19,0 -120.16% |
| Announcement Date | 17/05/19 | 29/05/20 | 04/06/21 | 27/05/22 | 29/05/23 |
Quarterly results
| Fiscal Period | März | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 19 734 19 656 0.4% | 16 347 15 077 8.42% | 16 575 14 835 11.73% | 13 105 15 907 -17.61% | 15 275 13 379 14.17% | 14 517 14 712 -1.32% | 15 995 14 983 6.75% | 15 525 15 581 -0.36% |
|
EBITDA Million INR | Released Forecast Spread | 3 746 5 128 -26.95% | 3 880 3 817 1.65% | 3 395 3 230 5.11% | 1 942 3 203 -39.35% | 2 474 2 069 19.55% | 1 924 2 341 -17.8% | 2 188 2 188 0% | 1 459 2 337 -37.58% |
|
EBIT Million INR | Released Forecast Spread | 2 884 4 208 -31.47% | 2 872 2 696 6.53% | 2 397 2 719 -11.84% | 1 009 2 530 -60.11% | 1 468 1 118 31.36% | 977 1 489 -34.37% | 1 248 1 206 3.48% | 516 1 639 -68.52% |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 3 236 3 778 -14.34% | 2 465 2 341 5.3% | 2 080 2 439 -14.7% | 702 2 270 -69.07% | 1 043 961 8.62% | 692 1 114 -37.87% | 391 881 -55.66% | 104 1 299 -92.01% |
|
Net income Million INR | Released Forecast Spread | 2 139 2 710 -21.07% | 1 605 1 822 -11.89% | 1 426 1 381 3.32% | 510 1 498 -65.96% | 596 636 -6.32% | 470 713 -34.03% | 54,9 647 -91.51% | -157 822 -119.06% |
|
EPS INR | Released Forecast Spread | 10,1 12,5 -19.28% | 8,97 7,50 19.6% | 3,74 4,65 -19.57% | 0,34 4,30 -92.09% | ||||
| Announcement Date | 04/06/21 | 23/07/21 | 22/10/21 | 04/02/22 | 27/05/22 | 02/08/22 | 21/10/22 | 03/02/23 |
More events
Past sector events for Jubilant Pharmova Limited
| Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| Today | AMGEN INC.: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 01/05/2024 11:45 | PFIZER, INC.: Q1 2024 Earnings Release |
| 01/05/2024 08:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 01/05/2024 07:00 | GSK PLC: Q1 2024 Earnings Release |
| 30/04/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- JUBLPHARMA Stock
- Calendar Jubilant Pharmova Limited
